Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

59
Number of overlapping holdings
92.2%
% of XLV's 65 holdings also in IYH
53.6%
% of IYH's 113 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus IYH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in IYH |
Overlap | |
---|---|---|---|---|
UNITEDHEALTH GROUP INC | 9.3% | 9.0% | 9.0% | |
JOHNSON & JOHNSON | 8.4% | 8.2% | 8.2% | |
ABBVIE INC | 5.8% | 5.6% | 5.6% | |
ELI LILLY & CO | 5.5% | 5.7% | 5.5% | |
MERCK & CO. INC. | 5.6% | 5.4% | 5.4% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to IYH
CVS CAREMARK CORP | 2.1% | |
MCKESSON CORP | 1.0% | |
METTLER-TOLEDO INTERNATIONAL | 0.7% | |
AMERISOURCEBERGEN CORP | 0.5% | |
WATERS CORP | 0.4% | |
UNITEDHEALTH GROUP INC | 0.3% | |
JOHNSON & JOHNSON | 0.2% | |
MERCK & CO. INC. | 0.2% | |
ABBVIE INC | 0.2% | |
ABBOTT LABORATORIES | 0.2% |
XLV Underweight Relative to IYH
SEATTLE GENETICS INC | -0.6% | |
HORIZON PHARMA PLC | -0.5% | |
VEEVA SYSTEMS INC-CLASS A | -0.5% | |
ALNYLAM PHARMACEUTICALS INC | -0.5% | |
BIOMARIN PHARMACEUTICAL INC | -0.3% | |
ROYALTY PHARMA PLC CLASS A | -0.3% | |
AVANTOR, INC. | -0.3% | |
EXACT SCIENCES CORP | -0.2% | |
QIAGEN NV | -0.2% | |
SAREPTA THERAPEUTICS INC | -0.2% |